← Research LibraryThe BriefFY2025 10-K · headline figures audited against SEC data
CVRx, Inc.: Revenue grew 10.4% to $56.65M from $51.29M. Net loss narrowed to $53.31M from $59.97M. Free cash flow outflow widened to $40.75M from $40.51M. Operating margin expanded 2549 bps to -90.49%. CVRx, Inc.'s annual comparison also shows the balance-sheet screen falls in the distress range and requires business-model context; the earnings-quality screen is grey.
The read at a glance✓ Audited against SEC data
- Growth — Revenue grew 10.4% to $56.65M from $51.29MOK
- Profitability — Net loss narrowed to $53.31M from $59.97MOK
- Cash flow — Free cash flow outflow widened to $40.75M from $40.51MWatch
- Margins — Operating margin expanded 2549 bps to -90.49%OK
- Accounting — Distress-range screen needs contextWatch
- Insiders — 2 purchases and 11 salesOK
Business
Autonomic activation is also a significant mechanism involved with multiple other cardiovascular diseases, such as hypertension, angina pectoris and cardiac arrhythmia, as well as other diseases, such as chronic kidney disease. 8 The role of the imbalance of ANS in HF The ANS, which is a PART of the peripheral nervous system, plays a vital role in the function of the heart.
Leadership changes
From CVRx, Inc.'s own filings, the day they're filed.
- Kevin Ballinger · directors · appointmenteff. 2024-09-03
- Ali Behbahani · director · departureeff. 2024-09-03
- Kevin Hykes · President · appointmenteff. 2024-02-12
Latest filings
- 8-K · Company announcement2026-08-11
- 10-Q · Quarterly report2026-08-06
- 8-K · Company announcement2026-08-06
- 8-K · Company announcement2026-06-09
- 8-K · Company announcement2026-06-03
In the full recordFree for 14 days
- What changed🔒
- Insider signal🔒
- Growth quality🔒
- Margins & accounting🔒
- Capital allocation🔒
- Real risks🔒
- The long arc🔒
- Company history🔒
- The filings, readable — with what changed vs the prior year highlighted🔒
- Full financial statements, industry-aware, sources cited throughout🔒
- Forensic score history & components — the trend, not one year🔒
- Ownership: insider buys/sells, clusters, activist stakes🔒
- Ana — ask about CVRx, Inc., every answer cited to the official filings🔒
Every figure comes from the company's filings, and analysis whose figures don't match SEC data is rejected before publication.
14-day free trial, no credit card. For research purposes only; not investment advice.